Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Chatterjee, Bithi; Sahli, Laura; Chijioke, Obinna; Went, Philip; Münz, Christian; Trojan, Andreas (2017). An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses. Haematologica, 102(10):e419-e422.

Egbring, Marco; Far, Elmira; Roos, Malgorzata; Dietrich, Michael; Brauchbar, Mathis; Kullak-Ublick, Gerd A; Trojan, Andreas (2016). A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. Journal of Medical Internet Research, 18(9):e238.

Stocker, Albina; Hilbers, Marie-Luise; Gauthier, Claire; Grogg, Josias; Kullak-Ublick, Gerd A; Seifert, Burkhardt; Varga, Zsuzsanna; Trojan, Andreas (2016). HER2/CEP17 ratios and clinical outcome in HER2-positive early breast cancer undergoing trastuzumab-containing therapy. PLoS ONE, 11(7):e0159176.

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Mwinyi, Jessica; Vokinger, Kerstin; Jetter, Alexander; Breitenstein, Urs; Hiller, Christian; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy. Cancer Chemotherapy and Pharmacology, 73(6):1181-1188.

Trojan, Andreas; Vergopoulos, Athanasios; Breitenstein, Urs; Tausch, Christoph; Seifert, Burkhardt; Joechle, Wolfgang (2013). CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients. Cancer Chemotherapy and Pharmacology, 71(2):301-306.

Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger (2013). Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE, 8(3):e58483.

Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger (2013). Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE, 8(10):online.

Trojan, Andreas; Vergopoulos, Athanasios; Breitenstein, Urs; Seifert, Burkhardt; Rageth, Christoph; Joechle, Wolfgang (2012). The Discriminatory Value of CYP2D6 Genotyping in Predicting the Dextromethorphan/Dextrorphan Phenotype in Women with Breast Cancer. Breast Care, 7(1):25-31.

This list was generated on Thu Sep 20 14:44:43 2018 CEST.